Cargando…
The splicing factor U2AF1 contributes to cancer progression through a noncanonical role in translation regulation
Somatic mutations in the genes encoding components of the spliceosome occur frequently in human neoplasms, including myeloid dysplasias and leukemias, and less often in solid tumors. One of the affected factors, U2AF1, is involved in splice site selection, and the most common change, S34F, alters a...
Autores principales: | Palangat, Murali, Anastasakis, Dimitrios G., Fei, Dennis Liang, Lindblad, Katherine E., Bradley, Robert, Hourigan, Christopher S., Hafner, Markus, Larson, Daniel R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499322/ https://www.ncbi.nlm.nih.gov/pubmed/30842218 http://dx.doi.org/10.1101/gad.319590.118 |
Ejemplares similares
-
Wild-Type U2AF1 Antagonizes the Splicing Program Characteristic of U2AF1-Mutant Tumors and Is Required for Cell Survival
por: Fei, Dennis Liang, et al.
Publicado: (2016) -
U2AF1 mutations alter splice site recognition in hematological malignancies
por: Ilagan, Janine O., et al.
Publicado: (2015) -
RECURRENT MUTATIONS IN THE U2AF1 SPLICING FACTOR IN MYELODYSPLASTIC SYNDROMES
por: Graubert, Timothy A., et al.
Publicado: (2011) -
Targeting of U2AF(65) to Sites of Active Splicing in the Nucleus
por: Gama-Carvalho, Margarida, et al.
Publicado: (1997) -
RNA structure replaces the need for U2AF2 in splicing
por: Lin, Chien-Ling, et al.
Publicado: (2016)